December 7, 2016
VIA EDGAR
Division of Corporation Finance
Securities and Exchange Commission
100 F Street N.E.
Washington, D.C. 20549
Attn: Suzanne Hayes, Assistant Director
| Re: | Amgen Inc. |
Registration Statement on Form S-4
File No. 333-214367
Acceleration Request
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations of the Securities and Exchange Commission (the “Commission”) promulgated under the Securities Act of 1933, Amgen Inc. (the “Company”) hereby requests that the effective date of the above-referenced Registration Statement on Form S-4 be accelerated to 4:00 p.m., Eastern Time, on December 9, 2016, or as soon as practicable thereafter.
The Company requests that it be notified of the effectiveness of the Registration Statement on Form S-4 by telephone call to its counsel Gregory P. Rodgers at (212) 906-2918, followed by written confirmation to the addresses listed on the cover page of the Registration Statement on Form S-4. Thank you for your attention to this matter.
| Very truly yours, |
| AMGEN INC. |
| /s/ Mary A. Lehmann |
| Mary A. Lehmann |
| Vice President, Finance and Treasurer |
| Amgen Inc. |
| cc: | Jonathan P. Graham |
| Amgen Inc. |
| Charles K. Ruck |
| Latham & Watkins LLP |
| Gregory P. Rodgers |
| Latham & Watkins LLP |